Manuscripts

Search by keyword, year, or author name.

Showing 1556 manuscripts.

Efficacy, Tolerability and Pharmacokinetics of Two Nelfinavir-Based Regimens in Human Immunodeficiency Virus-Infected Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol 403

Jennifer R. King, Sharon Appelbaum Nachman, Ram Yogev, Janice Hodge, Grace M. Aldrovandi, Michael Hughes, Jie (Ellen) Chen, Andrew A. Wiznia, Bharat Damle, Edward P. Acosta. Efficacy, Tolerability and Pharmacokinetics of Two Nelfinavir-Based Regimens in Human Immunodeficiency Virus-Infected Children and Adolescents: Pediatric AIDS Clinical Trials Group Protocol 403. Pediatric Infectious Disease Journal. 2005. 24: 880-885.

Year

2005

Journal

Pediatric Infectious Disease Journal

Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.

Walter T. Hughes, Wayne M. Dankner, Ram Yogev, Sharon Huang, Mary E. Paul, Midnela Acevedo Flores, Mark W. Kline, Lee-Jen Wei. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.. Clinical Infectious Diseases. 2005. 40: 136-45.

Year

2005

Journal

Clinical Infectious Diseases

Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to ZDV during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.

Andrea Kovacs, Mary K. Cowles, Paula Britto, Edmund Capparelli, Mary Glenn Fowler, Rita J. Jeremy, John ( Jack ) Moye, Kenneth McIntosh, Mobeen H. Rathore, Jane Pitt, Robert Husson. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to ZDV during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.. Pediatric Infectious Disease Journal. 2005. 24: 503-509.

Year

2005

Journal

Pediatric Infectious Disease Journal

An MDRI-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children.

Akihiko Saitoh, K. K. Singh, Christine Powell, Terence Fenton, Courtney V. Fletcher, Richard Brundage, Stuart E. Starr, Stephen A. Spector. An MDRI-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children.. AIDS. 2005. 19: 371-80.

Year

2005

Journal

AIDS

The rate of serious bacterial infection among HIV-infected children with immune reconstitution who have discontinued Opportunistic Infection prophylaxis.

Sharon Appelbaum Nachman, Philimon Gona, Wayne M. Dankner, Adriana Weinberg, Ram Yogev, Anne A. Gershon, Mobeen H. Rathore, Jennifer S. Read, Sharon Huang, Carol Elgie, Kimberly Hudgens, Walter T. Hughes. The rate of serious bacterial infection among HIV-infected children with immune reconstitution who have discontinued Opportunistic Infection prophylaxis.. Pediatrics. 2005. 115: e488-e494.

Year

2005

Journal

Pediatrics

Study

P1008

Immunological Response to Highly Active Antiretroviral Therapy in Children with Clinically Stable HIV-1 Infection.

Howard Max Rosenblatt, Kenneth Stanley, Lin-Ye Song, George M. Johnson, Andrew A. Wiznia, Paul Krogstad, Sharon Appelbaum Nachman, Andrew A. Wiznia, Paul Krogstad, Sharon Appelbaum Nachman. Immunological Response to Highly Active Antiretroviral Therapy in Children with Clinically Stable HIV-1 Infection.. Journal of Infectious Diseases. 2005. 192: 445-55.

Year

2005

Journal

Journal of Infectious Diseases

Ritonavir-Based Highly Active Antiretroviral Therapy In HIV-1 Infected Infants <24 Months of Age.

Ellen Gould Chadwick, John H. Rodman, Paula Britto, Christine Powell, Paul Palumbo, Katherine Luzuriaga, Michael Hughes, Elaine J. Abrams, Patricia M. Flynn, William Borkowsky, Ram Yogev. Ritonavir-Based Highly Active Antiretroviral Therapy In HIV-1 Infected Infants 24 Months of Age.. Pediatric Infectious Disease Journal. 2005. 24: 793 - 800.

Year

2005

Journal

Pediatric Infectious Disease Journal

Protease inhibitor combination therapy, severity of illness, and quality of life in children with perinatally acquired HIV-1 infection

Deborah S. Storm, Mary D. Boland, Steven Gortmaker, Yan He, Joan H. Skurnick, Lois C. Howland, James M. Oleske. Protease inhibitor combination therapy, severity of illness, and quality of life in children with perinatally acquired HIV-1 infection. Pediatrics. 2005. 115: e173-e182.

Year

2005

Journal

Pediatrics

Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life

Mark Mirochnick, Alice M. Stek, Midnela Acevedo, Margaret A. Keller, Diane Holland, Edmund Capparelli, James D. Connor, Sharon Huang, Michael Hughes, Lynne M. Mofenson, Yvonne J. Bryson. Safety and pharmacokinetics of nelfinavir co-administered with zidovudine and lamivudine in infants during the first 6 weeks of life. Journal of Acquired Immune Deficiency Syndromes. 2005. 39: 189-194.

Year

2005

Journal

Journal of Acquired Immune Deficiency Syndromes